Reference dashboard

HILT vs LLLT comparison dashboard

Compare High-Intensity Laser Therapy (e.g., iLux Smart, 1064 nm class IV) and Low-Level Laser Therapy devices side-by-side: power, wavelength, penetration, dose, and outcomes from musculoskeletal pain RCTs.

Side-elevation technical drawing of a Class IV 1064 nm Nd:YAG laser handpiece, in the Dieter Rams editorial style: monochrome line work with a single red beam accent. — FIG. 01 — APPARATUS, SIDE ELEVATION

Devices

1.6–25 W

HILT range

5–800 mW

LLLT range

RCT entries

What this dashboard compares

HILT and LLLT differ in three orders of magnitude on average power output, but they also differ in wavelength, pulse structure, and treatment dose. The tables below let you sort and filter the most clinically common platforms (e.g. ASA iLux Smart and Hiro, K-Laser Cube, LightForce, BTL-6000, plus LLLT references like THOR LX2, MR4 ACTIV, BioFlex) and cross-reference them against the dose / wavelength used in published RCTs.

How to read the numbers

01Peak power applies to pulsed emission (super-pulse devices reach kW peaks at very short duty cycles).
02Average power is what reaches the tissue across the whole session and drives dose calculations.
03Penetration depth is the depth at which 1/e of the surface fluence remains; longer wavelengths (1064 nm) penetrate further than visible red.
04Energy density (J/cm²) is the dose actually applied to the tissue — WALT recommends 4–10 J/cm² for LLLT, 8–14 J/cm² is typical for HILT.

HILT devices in view

Class IV

LLLT devices in view

Class IIIB

Avg power (HILT)

14.5 W

45 mm — typical depth

Avg power (LLLT)

259 mW

27 mm — typical depth

Filter devices

Class

Wavelength band

Max average power

25 WMAX

5 mW1 W10 W25 W

Device specifications


LightForce XLR8 Enovis / LightForce · FDA IV Up to 25 W deep-tissue therapy; influence-mode pulsing.	HILT Continuous · Pulsed	810 / 980 nm	25 W	25 W	40 mm	8–20 J/cm²	3–10 min
K-Laser Cube 4 K-Laser USA · FDA IV Four-wavelength dynamic emission; 970 nm targets water.	HILT Continuous · Pulsed · ISP	660 / 800 / 905 / 970 nm	15 W	15 W	40 mm	6–12 J/cm²	4–10 min
BTL-6000 High Intensity Laser BTL Industries · FDA IV Nd:YAG-class 1064 nm; common in European RCTs.	HILT Continuous · Pulsed	1064 nm	12 W	12 W	45 mm	8–14 J/cm²	8–12 min
Hiro TT (HILT) ASA Laser · FDA IV High peak power (kW), short duty cycle; 1064 nm.	HILT Pulsed (super-pulse)	1064 nm	3.0 kW	10.5 W	50 mm	10–12 J/cm²	10–15 min
iLux Smart ASA Laser · FDA IV Nd:YAG-equivalent 1064 nm; chromophore-selective heating with cooling tip.	HILT Continuous · Pulsed	1064 nm	12 W	10 W	50 mm	8–14 J/cm²	8–15 min
MLS M6 ASA Laser · FDA IIIB/IV Patented dual-wavelength locked emission; bridges LLLT and HILT.	MLS Synchronised continuous + pulsed	808 / 905 nm	75 W	3.3 W	35 mm	4–8 J/cm²	10–15 min
Intelect Laser Chattanooga / DJO · FDA IIIB Common rehab clinic LLLT; 980 nm option for deeper targets.	LLLT Continuous · Pulsed	660 / 830 / 980 nm	500 mW	500 mW	30 mm	4–8 J/cm²	3–10 min
Apollo Cold Laser Pivotal Health · FDA IIIB Mid-range LLLT at the upper edge of Class IIIB output.	LLLT Continuous · Pulsed	810 / 830 nm	500 mW	500 mW	30 mm	4–8 J/cm²	2–8 min
BioFlex Pro Meditech BioFlex · FDA IIIB Cluster array allows higher delivered fluence per session.	LLLT Continuous + cluster array	660 / 830 nm	300 mW	300 mW	30 mm	4–10 J/cm²	10–20 min
THOR LX2 THOR Photomedicine · FDA IIIB WALT-protocol reference device for many MSK pain RCTs.	LLLT Continuous	660 / 810 nm	200 mW	200 mW	30 mm	4–6 J/cm²	1–5 min
Multi Radiance MR4 ACTIV Multi Radiance Medical · FDA IIIB Super-pulsed 905 nm peaks (kW range) with very low average power.	LLLT Super-pulsed + cluster	660 / 875 / 905 nm	25 W	50 mW	30 mm	4–8 J/cm²	1–3 min
Erchonia PL5 Erchonia · FDA IIIB Low-output cold laser; FDA-cleared for several MSK indications.	LLLT Pulsed (sweep)	635 / 405 nm	5 mW	5 mW	10 mm	0.5–2 J/cm²	10–20 min

HILT vs LLLT at a glance

HILT

HILT — Class IV

e.g., iLux Smart, Hiro TT, K-Laser Cube, LightForce, BTL-6000

Average power: 1.6–25 W
Peak power (pulsed): Up to 3 kW (super-pulse)
Wavelengths: 808 / 905 / 970 / 980 / 1064 nm
Penetration: 40–50 mm (1064 nm best)
Typical dose: 8–14 J/cm²
Session length: 8–15 min
Mechanism: Photothermal + photochemical (selective heating)
Best for: Deep MSK pain — LBP, knee OA, shoulder, plantar fasciitis

LLLT

LLLT — Class IIIB

e.g., THOR LX2, MR4 ACTIV, BioFlex, Erchonia, Apollo, Intelect

Average power: 5 mW – 800 mW
Peak power (pulsed): Up to 25 kW super-pulsed (very short)
Wavelengths: 405 / 635 / 660 / 810 / 830 / 904 nm
Penetration: 10–30 mm
Typical dose: 4–10 J/cm² (WALT)
Session length: 1–20 min
Mechanism: Photochemical (cytochrome c oxidase / ATP)
Best for: Superficial tendinopathy, neck pain, wound healing

Clinical outcomes — RCT evidence

Condition

Class

								Citation
Chronic low back pain	HILT	1064 nm Nd:YAG (Hiro)	1064	12	12	73%	12	Alayat MS et al., Lasers Med Sci 2014;29(3):1065-73.
Plantar fasciitis	HILT	1064 nm HILT	1064	12	12	70%	4	Cinar E et al., Lasers Med Sci 2018;33(5):949-58.
Knee osteoarthritis	HILT	1064 nm HILT	1064	12	12	67%	6	Kheshie AR et al., Lasers Med Sci 2014;29(4):1371-6.
Chronic low back pain	HILT	1064 nm HILT	1064	11	15	65%	3	Fiore P et al., Eur J Phys Rehabil Med 2011;47(3):367-73.
Subacromial impingement	HILT	1064 nm HILT	1064	10	10	65%	3	Santamato A et al., Phys Ther 2009;89(7):643-52.
Chronic neck pain	HILT	Hiro 1064 nm	1064	10	10	60%	4	Salli A et al., Lasers Med Sci 2010;25(5):743-9.
Chronic neck pain	LLLT	THOR-class 830 nm	830	5.4	14	55%	12	Chow R et al., Lancet 2009;374(9705):1897-908 (meta-analysis).
Subacromial impingement	MLS	MLS 808/905 nm	905	6	10	55%	4	Angelova A, Ilieva EM. Folia Med 2016;58(2):99-104.
Frozen shoulder	LLLT	BioFlex 660/830 nm cluster	830	6	12	50%	8	Ip D, Fu NY. Clin Interv Aging 2015;10:1257-61.
Plantar fasciitis	LLLT	830 nm LLLT	830	8	8	45%	12	Macias DM et al., J Foot Ankle Surg 2015;54(5):768-72.
Tendinopathy (mixed)	LLLT	WALT-protocol 820–904 nm	904	4	10	40%	4	Bjordal JM et al., BMC Musculoskelet Disord 2008;9:75.
Knee osteoarthritis	LLLT	904 nm super-pulsed (MR4-class)	904	6	9	38%	4	Kingsley JD et al., Lasers Med Sci 2014;29(4):1357-64.

Effect-size caveats

VAS reduction percentages are point estimates from the cited papers and reflect the intervention arm change, not always the between-group difference vs sham. Heterogeneity across studies (dose, sessions, control type) limits direct head-to-head comparison. Use this dashboard for orientation; verify against the underlying paper before clinical decisions. Dose ranges follow WALT (LLLT) and IFU guidance (HILT) and are not a substitute for device-specific protocols.

Why power and wavelength both matter

Wavelength determines which chromophore absorbs the photon. 1064 nm sits in the “optical window” with low absorption by water and haemoglobin, allowing it to reach the deep paraspinals or rotator cuff with usable fluence. 808–830 nm targets cytochrome c oxidase efficiently but attenuates faster. 660 nm is largely superficial.

Power determines how much energy you can deliver per unit time without the session running into clinical impracticality. A 200 mW LLLT probe needs ~50 s/cm² to deliver 10 J/cm²; a 10 W HILT delivers the same dose in a single second — which is why HILT sessions can paint over multiple cm² in 8–15 min while LLLT spot-treats fewer points.

Pulse structure (super-pulsed peaks vs continuous wave) shifts the balance between photochemical and photothermal effects. Most modern HILT platforms (and MLS) deliberately combine both modes within a single protocol.

Devices do not live on a strict HILT/LLLT binary. MLS systems and some super-pulsed Class IIIB platforms occupy a middle band: low average power but very high peak power. The class label tells you regulatory tier; the dose, wavelength, and session structure tell you what actually reaches the tissue.

Reference dashboard · 12 DEV · 12 RCT